Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Tolerability”

18,992 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 18,992 results

Large-scale testing (Phase 3)Study completedNCT01201356
What this trial is testing

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 4,125
Testing effectiveness (Phase 2)Study completedNCT01332695
What this trial is testing

A Pilot Efficacy and Safety Study of ST101 in Essential Tremor

Who this might be right for
Essential Tremor
Sonexa Therapeutics, Inc. 25
Not applicableStudy completedNCT00711139
What this trial is testing

Long-term Safety and Tolerability of AFFITOPE AD01

Who this might be right for
Alzheimer's Disease
Affiris AG 22
Large-scale testing (Phase 3)WithdrawnNCT01124877
What this trial is testing

Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)

Who this might be right for
Bipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Testing effectiveness (Phase 2)Study completedNCT01928381
What this trial is testing

Safety, Tolerability and Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With PDN and Good Pain Reporting Ability

Who this might be right for
Diabetic Neuropathy, Painful; Diabetic Neuropathies
AstraZeneca 150
Testing effectiveness (Phase 2)Study completedNCT04835519
What this trial is testing

Phase I/II Study of Enhanced CD33 CAR T Cells in Subjects With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaRelapse LeukemiaRefractory Acute Myeloid Leukemia
Beijing Boren Hospital 5
Early research (Phase 1)Study completedNCT01346319
What this trial is testing

Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecanoate in Hypogonadal Males.

Who this might be right for
Hypogonadal Males
Abbott
Testing effectiveness (Phase 2)Study completedNCT00711230
What this trial is testing

Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients

Who this might be right for
HIV Infection
Genetic Immunity 36
Large-scale testing (Phase 3)Ended earlyNCT05681481
What this trial is testing

Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid

Who this might be right for
Bullous Pemphigoid
argenx 64
Early research (Phase 1)Study completedNCT02104765
What this trial is testing

LY2951742 in Healthy Japanese and Caucasian Participants

Who this might be right for
Migraine Disorders
Eli Lilly and Company 45
Testing effectiveness (Phase 2)Study completedNCT01888367
What this trial is testing

Safety, Efficacy and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal Surgery

Who this might be right for
Surgical Site Infections
Dr. Reddy's Laboratories Limited 445
Early research (Phase 1)Study completedNCT04532567
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of GLPG1205 in Healthy Japanese and Caucasian Male Subjects

Who this might be right for
Healthy
Galapagos NV 32
Early research (Phase 1)Looking for participantsNCT06809400
What this trial is testing

LY4006896 in Healthy Participants and Participants With Parkinson's Disease

Who this might be right for
Parkinson Disease
Eli Lilly and Company 127
Early research (Phase 1)Study completedNCT02316756
What this trial is testing

A Single Ascending Dose Study To Evaluate Safety And Pharmacokinetics Of Compound PF-06648671 In Healthy Subjects

Who this might be right for
Healthy Subjects
Pfizer 18
Large-scale testing (Phase 3)WithdrawnNCT03532022
What this trial is testing

Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy

Who this might be right for
Congenital Adrenal Hyperplasia
Neurocrine UK Limited
Early research (Phase 1)UnknownNCT03015922
What this trial is testing

Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Leeds 4
Large-scale testing (Phase 3)Study completedNCT00391131
What this trial is testing

Subcutaneous Ig NextGen 16% in PID Patients

Who this might be right for
Primary Immunodeficiency (PID)
CSL Limited 35
Early research (Phase 1)Study completedNCT05327231
What this trial is testing

IN10018 Monotherapy or in Combination With Docetaxel in Gastric or GEJ Adenocarcinoma

Who this might be right for
Gastric Cancer
InxMed (Shanghai) Co., Ltd. 33
Large-scale testing (Phase 3)Looking for participantsNCT07250802
What this trial is testing

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Takeda 110
Early research (Phase 1)Study completedNCT02340572
What this trial is testing

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRS-080

Who this might be right for
Healthy
Pieris Pharmaceuticals GmbH 48
Load More Results